pain gain question frutarom
may
buy frutarom appear make good strateg sens
strong exposur natur sale fast-grow local region custom
access high-growth adjac technolog frutarom first glanc everi buyer dream
though fear stretch given mount pressur acquir
note might buy frutarom lag peer a/ diversif
fear stretch keep pace peer consid high
multipl paid ebitda stretch balanc sheet signific equiti
rais sharehold unlik forgiv integr challeng deal
mani question remain deliv
embark largest complex integr project histori
sector mani question remain capabl undertak monument like
messi integr given patchi oper track record rel valuat
peak level good frutarom asset extent integr long
could integr take much could cost deal mean
best cautiou near-term given trough rel valuat stay neutral
doubt emerg victori post integr becom lead player
tast scent nutrit yet multipl execut risk pend equiti rais
adj ep consensu see limit catalyst near-term share price
recoveri fair valu set trough discount givaudan impli
stay neutral
question manag
enclos question manag could address provid confid
exan bnpp estim thomson reuter consensu list currenc dividend reinvest
date time london time invest recommend finalis may differ date time broad dissemin
websit appendix analyst certif import disclosur non-u research analyst disclosur
price may target price
price yearli average dec dec
share year end basic
average share dilut excl treasuri stock
 rel usa
liabil commit
chang wcr
increas decreas net financi debt
rel usa usd
intang per share adjust capit gains/loss impair charg except restructur charg capit pension charg replac servic cost
 adj capit gain loss imp charg capit intang except restructur list currenc ith div reinvest also adjust intang gw ill pre ifr year
acquir frutarom
frutarom
strateg benefit
question manag
invest case valuat risk
compani profil financi highlight
buy frutarom appear make good strateg sens
strong exposur natur sale fast-grow local region
custom access high-growth adjac technolog frutarom first glanc
figur frutarom strateg benefit
benefit
broaden exposur natur
increas access faster-grow rs privat label
access faster-grow technolog
access enzym food protect color etc
frutarom exposur ce europ
estim year
though fear stretch given mount pressur
acquir
note might buy frutarom lag peer
diversifi portfolio yet take-over frutarom fear
compani stretch keep pace peer consid
high multipl paid ebitda stretch balanc sheet signific
equiti rais sharehold unlik forgiv integr challeng
deal
unit shown
mani question remain deliv
embark largest complex integr project
histori sector mani question remain capabl undertak
monument like messi integr given patchi oper track record
rel valuat peak level good frutarom asset
extent integr long could integr take much
could cost deal mean near-term organ growth
figur frutarom key question mark
frutarom asset good
seamlessli execut monument integr
well frutarom asset integr
manag execut frutarom pipelin
could see near-term disrupt organ growth
frut appear mix bag great good not-so-good asset
even best face challeng limit experi
frutarom global platform risk cash cost
question near-term given stretch b/ like resourc
constraint willing seller
scope initi indigest dis-synergi
best cautiou near-term given trough rel valuat
doubt emerg victori post integr becom
lead player tast scent nutrit yet multipl execut risk pend
equiti rais adj ep consensu see limit
catalyst near-term share price recoveri fair valu set trough
discount givaudan impli stay neutral
figur trade discount givaudan trough
figur valu compani ev/ebitda multipl
question manag
enclos question manag could address provid
confid deal top question
feel comfort execut capabl given limit track
record larg seemingli volatil oper histori
give confid bulk integr done
year preced major transform process appear
acquir frutarom
acquir frutarom largest deal histori sector
highlight deal
surpris market last week offer frutarom structur
offer shown frutarom sharehold receiv cash per
share share common stock fix price
figur offer frutarom
frutarom pension bn
cash-per-share split equiti valu
offer reflect multipl frutarom ebitda forecast
includ full run-rat cost synergi estim year
figur frutarom key multipl without synergi
exan bnp pariba estim synergi expect realis year
agreement unanim approv board director
transact expect close six nine month subject approv
frutarom sharehold clearanc relev regulatori author
customari close condit major sharehold icc industri
share vote favour transact
follow close deal yehudai presid ceo frutarom
serv strateg advisor support andrea fibig current chairman
ceo
remain headquart new york citi stock close list
new york tel aviv stock exchang
iff state rational deal elabor later report
strengthen posit natur gain exposur faster grow adjac
andrea ceo comment
transact big win fantast outcom sharehold custom
employe compani
frutarom extrem attract product portfolio includ broad expertis
natur divers adjac capabl beyond core tast scent
busi also signific exposur complementari fast-grow small-
mid-siz custom combin deep expertis frutarom
offer custom broader rang solut acceler
growth strategi believ combin lead faster profit
growth enhanc free cash flow gener greater return
frutarom valuat peak level record rel high vs
figur frutarom trade record high vs
frutarom valuat new peak
frutarom trade record high vs
believ time may driven time coincid sever factor
frutarom believ
question mark success ceo current year old icc
chairman john farber coincid record high sector valuat like
prompt manag explor potenti exit
frutarom phenomen track record doubl sale everi year
sinc see page harder achiev achiev target
call frutarom explor strateg option
iff perspect believ
lag givaudan symris term compani
target new sale part strategi
achiev half far slower embrac adjac
figur recent deal mainli core area
adjac
adjac dri technolog dehydr fruit veg
present cagni feb howev suggest strateg evolut
greater focu around drive differenti maximis portfolio
figur iff refresh strategi call greater differenti
want broaden busi differenti
given givaudan numer acquisit past year symris strong
growth help broad portfolio believ may
increas pressur acquir catch peer import
consider busi focus givaudan firmenich
symris realiti similar explicitli state fulli
replac one anoth impli one two peer start diversifi
mount pressur other keep jone
particular case bertram andrier
similar situat last seen acquir luca meyer cosmet june
record-break sale rational deal add activ
cosmet fragranc busi follow footstep symris
sale cosmet ingredi givaudan alreadi acquir solianc
symris post diana givaudan post naturex increasingli promot
strong posit natur rs adjac frutarom offer one-shot
opportun catch peer
ingredi corpor seek target view compet offer
unlik sheer size transact high multipl paid question mark
target qualiti discuss later report like make deal no-
go
profess love andrea see post-deal
confer call hard imagin frutarom justifi combin anoth
excerpt post-deal confer call
andrea fibig
yehudai mani reason first guy talk andrea
think way got love decid go even though
bidder interest parti less attract
frutarom would say seriou note even though previou one
truth mean look mani flavour specialti fine ingredi
relev space investor interest frutarom
money look
admir sinc join industri year ago sure
includ excel colleagu admir combin compani
go forward right way
frutarom
frutarom diversifi player expos flavour adjac
frutarom intern flavour fine ingredi busi base israel
claim posit flavour associ system run-rat sale
estim
sale activ
sale geographi pf
frutarom pf run rate fulli incorpor deal announc
tast solut involv sweet savouri flavour solut includ
food system use mainli food beverag consum product claim
leadership value-ad function savouri solut uniqu technolog
fruit spice veget meat fish prepar
fine ingredi involv innov science-bas health ingredi
nutrit cosmet person care product includ specialti botan
extract essenti oil well natur color antioxid antimicrobi
trade market involv sell materi sourc third parti
busi gener lower margin offer servic strengthen
frutarom relationship custom
busi grown sale sinc compound-annual-growth-rate ebitda
net profit much driven deal report
past decad
figur deal announc past decad
 core part frutarom strategi two deal alreadi report year date
twelv understand ceo cfo person
activ involv sourc execut
compani mid-term target reach sale organ
growth core ebitda margin compani strong
figur frutarom target ambiti compani strong track record sale growth
frutarom doubl sale everi year usd million
compani largest sharehold icc industri new york-bas
hold compani invest chemic pharma plastic compani icc
family-own compani chair dr john farber age famili held
interest frutarom sinc ahead public list tel aviv
scotia
rest share held variou institut sharehold note ceo
largest sharehold nearli capit
frutarom background strategi cover present overview
key financi
compani exan bnp pariba estim pf constant fx growth assum announc
alreadi consolid year
organ growth averag past year slightli ahead line
mid-term ambit grow
exan bnp pariba estim frutarom includ organ growth acquir target pf
frutarom margin touch lower iff driven exposur low margin
trade activ sale mix frut fine fragranc exposur
yet manag see upsid target aim core ebitda margin
would impli group ebit margin line
exan bnp pariba estim note iff flavor margin directli compar exclud
corpor cost disclos separ line item
work capit touch higher perhap driven divers product
base product
figur work capit scope minor improv
strateg benefit
frutarom first glanc everi buyer dream
broad portfolio natur good access local region custom
emerg market exposur frutarom first glanc appear everi buyer
dream exposur look highli complementari iff exist portfolio
figur frutarom strateg benefit
benefit
broaden exposur natur
increas access faster-grow rs privat label
access faster-grow technolog
access enzym food protect color etc
frutarom exposur ce europ
estim year
broad portfolio natur solut
frutarom estim busi natur compani
involv flavour associ tast system also offer exposur
number high growth market includ natur colour natur food protect
varieti health ingredi pharmaceut nutraceut cosmet
figur frutarom offer signific exposur natur
compani exan bnp pariba estim note group level figur
divers portfolio like caught iff attent mani closest
peer start acquir adjac broaden offer natur
solut custom
figur mani iff peer broaden adjac
symris earli embrac adjac
givaudan acquir naturex broaden offer
breadth view platform de-lev
mani ingredi compani activ invest organ
 increas exposur local region custom broad bucket
custom less known investor compar larg unilev nestl
world aggreg account lion share global food beverag
figur multin repres small fraction global market
custom group gener speak seen stronger growth vs
averag multi-national given greater agil flexibl embrac new innov
better understand local consum estim rs privat
label aggreg grown market growth
frutarom hold strong long-term relationship mani local region
custom aggreg account sale
figur frutarom favour custom mix
compani exan bnp pariba estim note group level figur
frutarom also strong relationship privat label custom offer
signific potenti group remain under-penetr mani market qualiti
standard improv anecdot evid suggest willing
invest high qualiti ingredi compet differenti vs
figur privat label market share countri huge penetr potenti
much like frutarom gener signific amount sale emerg
market key exposur includ central eastern europ latin america
asia highli complementari iff em exposur
current limit ce europ signific asia
figur frutarom signific exposur emerg market
valu creation extract synergi
estim run-rat synergi full year integr
benefit come combin
procur acceler rationalis harmonis
infrastructur optimis global footprint
addit yet quantifi revenu synergi expect cross-sel
go forward expect see acceler organ growth higher ebitda margin
enhanc cash flow gener
mani question remain sharehold unlik forgiv
execut challeng given stretch natur deal
iff plan acquir frutarom seem make good strateg sens
doubt time creat valu deal yet given sheer size
transact largest histori sector believ fair
detail look potenti risk ahead
figur frutarom key question mark
frutarom asset good
seamlessli execut monument integr
well frutarom asset integr
manag execut frutarom pipelin
could see near-term disrupt organ growth
frut appear mix bag great good not-so-good asset
even best face challeng limit experi
frutarom global platform risk cash cost
question near-term given stretch b/ like resourc
constraint willing seller
scope initi indigest dis-synergi
frutarom asset good
anecdot evid broader industri suggest mani frutarom
product technolog acquisit target low qualiti difficult
assess disclosur limit food scientist note frutarom
averag sale per product assum peer use definit
product much lower larger peer could suggest
figur frutarom lowest usd sale per product
product
look deal also reveal number curious low multipl transact
sale may suggest lack compet buyer surpris today
seller market even larger player activ seek small digit
million sale asset may implic qualiti busi
figur frutarom deal curious low multipl
savouri flavour sweet tast solut sa
flavor specialti fine natur ingredi franc
brazilian produc tast solut ice cream dessert
flavour natur colour uk
fragranc solut israel
flavour savour solut thailand compound-annual-growth-rate
nutrit ingredi medic food
savouri solut brazil
activ natur ingredi cosmet supplement compound-annual-growth-rate
 argentina higher margin frutarom flavor
compani exan bnp pariba estim target assum carri debt confirm
mean state frutarom deal low qualiti
enzymotec ibr exampl recent high qualiti target compani
like mix bag great good not-so-good qualiti asset
well realli know frutarom asset
asid topic asset qualiti note rel newcom
 circuit aromor first deal year silent period
focu past ceo doug tough last strategi focus
organ improv emerg market penetr strengthen improv
return portfolio clean renew effort particularli critic
period under-invest fallen behind fragranc
andrea fibig leadership extern growth becam
figur recent step focu
strategi doug tough
 explicit focu andrea fibig strategi
interest consider may impli involv prior
 due dilig process concern mani asset acquir frutarom
iff peer may dismiss frutarom target given intim
knowledg asset base
seamlessli execut monument integr
busi transform programm integr project highli
disrupt organis even best oper face challeng
illustr provid two exampl givaudan short period slower
growth post integr quest peer spoken sale dis-synergi
kerri challeng emea end transform
figur transform initi disrupt even best
givaudan organ growth slow integr quest
kerri emea busi slow busi
mind seem fair wonder fare embark largest
like complex integr project histori sector
pertin question note perceiv market much
volatil financi oper vs closest european peer
number oper issu highlight year may attribut bad
luck recur natur except event rais question
number recent disclos issu led earn miss
estim shown
chines flavor site close week given odour issu reduc margin
figur multipl oper issu recent year
organ sale due custom destock custom rationalis issu china
chines govern request reloc ingredi site zhejiang
manufactur issu custom bankruptci fda mandat product recal litig loss
plant reloc india lab closur taiwan
potenti re-zon guangzhou flavour plant
mind sure iff integr seamless
well frutarom asset integr
member capit market describ frutarom sort turkish
bazaar given percept collect non-integr asset
frutarom repeatedli spoken make attempt integr deal
drive synergi still question whether commerci oper
standpoint fulli integr extent would expect
understand compani global platform although
proprietari system develop control monitor activ
global system view unnecessari date due local diversifi
natur busi model keep decentralis structur also help preserv
cultur individu target local agil
proprietari system may effect reason believ
far would expect larger acquir view global
platform necess oper complex broad mix busi
haunt memori quest case studi also serv bitter remind
import invest sap
risk sap quest case studi
risk proper sap platform last observ quest
own ici profit warn unabl locat raw materi
fail deliv time custom inexcus offenc industri
result quest lose lot custom sale guidanc yoy follow
string profit warn busi acquir givaudan
see risk addit cash cost
fear integr frutarom mani asset incur materi addit cash out
synergi benefit current guid
difficult take accur view cost without knowledg
legaci proprietari system place level integr lack
tabl give indic expens incur givaudan kerri
figur transform sap project costli
compani exan bnp pariba estim note kerri cost estim later increas
scope project increas
assum frutarom sale integr cost would impli
addit integr expens
manag execut frutarom pipelin
 key part frutarom strategi deal announc
past decad iff intent continu select execut frutarom
 pipelin understand addit yet execut
includ mid-term financi model transact
step capabl recent year recent
success luca meyer tastepoint grow d-d yet abil
execut addit deal midst integr sector largest
complex transact question view
risk see
resourc avail embark largest complex
 integr project ever sector enough capac sourc
execut addit deal
fund highli lever balanc sheet risk de-lever
ambit see integr risk spend cash
sourc understand frutarom approach ceo
alon cfo person activ involv court potenti target
execut pipelin andrea rich capac visit
small target mani year
seller appetit part beauti acquir non-integr
busi like frutarom cultur busi left larg undisturb
will frutarom small target join multi-national giant like
asid note frutarom aggress strategi one
reason manag grow innov despit small expenditur
 may impli execut slow may need invest
 maintain frutarom organ growth
figur frutarom expenditur small vs peer given activ pipelin
exan bnp pariba estim division estim base sale
could see short-term disrupt organ growth
frutarom believ combin organis result higher
growth margin cash flow gener potenti cross-sel product
excit long-term opportun see risk short-term bump road
driven factor
sale dis-synergi two compani limit overlap see risk
minor sale dis-synergi especi multi-national custom frutarom
sku reduct may find number busi low return
margin decis cull could result lower organ growth
custom loss note went period portfolio prune improv
return
centralis effici cite footprint optimis driver cost
synergi intent frutarom salesforc remain seen look
averag sale gener per employe reveal frutarom people-intens
busi like due fragment custom base decentralis
approach mani small product sold mani small custom attempt
centralis improv effici could result custom loss
figur frutarom custom
product
custom
execut risk multi-ingredi busi offer
acquir frutarom evolv rel focus busi
broader multi-ingredi approach risk multi-ingredi approach vs
integr solut kerri sens result valu destruct
form price concess manag appropri recent outlin
risk note integr solut kerri dark hors deserv premium
strateg merit question execut asid main push back deal
sky high take multipl forward ebitda section outlin
financi implic introduc pro-forma estim
key financi term offer follow
frutarom sharehold receiv frutarom share cash
share common stock fix price
amount total equiti valu enterpris valu
frutarom sharehold also receiv special dividend equal per
share valu dividend closur deal
figur offer frutarom
frutarom pension bn
cash-per-share split equiti valu
cash portion transact fund mix cash
stock guid rais billion new equiti frutarom
sharehold base fix share price impli
share portion fund equiti issu
impli full ev fund new
share cash
figur billion deal fund new stock
portion offer
retir frutarom net debt
share portion offer
total cash-per-share split ev
achiev year
expect cost synergi third full year close
synergi come procur footprint optimis streamlin
addit cross-sel opportun integr solut expect
provid revenu synergi creat valu sharehold time
cost extract synergi estim benefit
guidanc
pf net debt adjust ebitda close expect
expect de-lev net debt adjust ebitda lower within
month close commit maintain invest grade credit rate
priorit de-lever anticip strong cash flow gener
support goal plan suspend share repurchas target met
deal cash ep neutral year double-digit accret year
meet cost capit year
overleaf present main financi effect deal assum
frutarom consolid start
cost synergi year guid cost benefit
addit integr cost sale estim time year
key metric simul shown
unit shown
frut stock offer
fund cash offer
sale
trade price-to-earnings ebitda consensu number
discount givaudan vs histor
figur trade discount givaudan consensu figur
overview valuat forecast rel consum
ingredi peer relev peer givaudan symris kerri
estim consolid givaudan naturex frutarom
current trade discount givaudan
chang estim
outlin chang estim reflect integr frutarom
jan show iff-adjust exane-adjust adj ppa cash ep
figur chang exan ep estim
exan bnp pariba estim consolid frutarom jan
price-to-earnings multipl base ep metric shown
believ use cash ep fair compar peer
although note market iff guidanc consensu estim
tend focu iff-adjust non-gaap ep
figur current price-to-earnings valuat exan iff-adjust ep figur
lastli estim vs consensu shown believ
contributor consolid frutarom forecast
cut tp
calcul fair valu stock appli target ev/ebitda
previous valu ev/ebitda discount
impli multipl givaudan line histor averag reflect iff
greater volatil choppi oper track record
view discount fair given mani risk associ integr
frutarom revis tp impli ebitda
discount target multipl givaudan
figur valu compani ev/ebitda multipl
figur trade discount givaudan trough
near-term reserv frutarom integr process
like overhang pend equiti rais new fair valu impli
upsid maintain neutral rate
question manag
much due dilig done construct offer
explain time deal
feel comfort execut capabl given limit track
record larg seemingli volatil oper histori
give confid bulk integr done
year preced major transform process appear
believ import global sap platform
budget arriv estim
manag integr team incentivis
manag conflict keep decentralis oper
reap effici scale
forese sale dis-synergi even small initi phase
integr cross-sel benefit come
forese dispos integr
long frutarom current manag employ
ensur key staff sale retain post integr
lot discuss past potenti iff-symris
combin chang
comfort execut frutarom pipelin
extent manag directli involv court small target like
perceiv competit posit vs closest peer follow
understand integr solut benefit
histor focus player explain recent strateg
evolut toward diversifi busi
pf organ growth expect follow integr
target higher pf margin peer believ cap
profit high margin realist go
assumpt behind synergi guidanc view
gross net figur
view main lever improv pf cash flow gener
assumpt use get meet wacc year
impact except invest usual target wacc
year mean execut compens
estim ppa cost deal non-gaap ep
adjust
riski take much leverag busi environ
unpredict volatil raw materi cost eat cash flow quit
perceiv main opportun risk relat deal
view share price reaction post announc
ebit non-gaap new
incom tax
tax incom
pay
invest case valuat risk
share under-perform given market concern frutarom deal
doubt emerg victori post integr multipl
execut risk pend equiti rais adj ep
consensu see limit catalyst near-term share price recoveri
fair valu set trough discount givaudan impli
upsid
upsid risk includ materi uptick demand rapid declin raw materi
price market share gain value-accret faster expect execut
synergi favour chang fx especi usd/eur
downsid
downsid risk includ materi slowdown chang demand rapid increas
raw materi price loss price power increas competition/market share
loss oper issu value-destruct execut issu
frutarom deal materi chang fx especi usd/eur
